生物、合成和长效可吸收补片在腹疝修补中的长期性能比较:种群生存动力学方法。

IF 3.8 2区 医学 Q1 SURGERY
Abdulaziz Elemosho, Jeffrey E Janis
{"title":"生物、合成和长效可吸收补片在腹疝修补中的长期性能比较:种群生存动力学方法。","authors":"Abdulaziz Elemosho, Jeffrey E Janis","doi":"10.1097/XCS.0000000000001412","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Long term follow-up outcomes of ventral hernia repairs (VHRs) with meshes are unavailable. Knowledge of these meshes at distant timepoints will be useful in selecting optimal mesh for VHRs. Our study aims to develop a highly accurate model to validate and predict long-term recurrence data of open VHRs and further determine the optimal timing of follow up for different VHRs with different meshes.</p><p><strong>Study design: </strong>Using population survival kinetics, one-phase non-linear regression analysis (NLRA) was used to determine the overall time-to-recurrence for repairs with all three mesh types. Time-to-recurrence was used to validate and predict the year-over-year recurrence data for each specific mesh type.</p><p><strong>Results: </strong>The model found the median overall time-to-recurrence to be longest for long-acting resorbable meshes (166.4 months), followed by synthetic meshes (132.1 months), and shortest for biologic meshes (80 months). At 5 years, about 41% of VHRs with biologic meshes, 27% with synthetic meshes, and 22% with long-acting resorbable meshes are expected to fail due to recurrence; at 10 years, these rates will rise to 65%, 47%, and 39%, respectively. Biologic meshes will have the highest proportion of \"at-risk\" repairs (42%). At 15-years post-repair 98-99% of the remaining unrecurred VHRs in the biologic and synthetic meshes will remain intact beyond that timepoint. Patients who had VHR with biologic and synthetic mesh should be evaluated for recurrence every 6 months for 2 years, then yearly up to 15 years. Patients repaired with long-acting resorbable meshes should be evaluated for recurrence starting at 12-18 months post-repair, then yearly.</p><p><strong>Conclusions: </strong>We demonstrate the first application of population survival kinetics in the surgery literature. Long-acting resorbable meshes have the longest time-to-recurrence and the lowest recurrence rates over 5 and 10 years, suggesting superior long-term performance compared to synthetic and biologic meshes.</p>","PeriodicalId":17140,"journal":{"name":"Journal of the American College of Surgeons","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparative Long-Term Performance of Biologic, Synthetic, and Long-Acting Resorbable Meshes in Ventral Hernia Repair: Population Survival Kinetics Approach.\",\"authors\":\"Abdulaziz Elemosho, Jeffrey E Janis\",\"doi\":\"10.1097/XCS.0000000000001412\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Long term follow-up outcomes of ventral hernia repairs (VHRs) with meshes are unavailable. Knowledge of these meshes at distant timepoints will be useful in selecting optimal mesh for VHRs. Our study aims to develop a highly accurate model to validate and predict long-term recurrence data of open VHRs and further determine the optimal timing of follow up for different VHRs with different meshes.</p><p><strong>Study design: </strong>Using population survival kinetics, one-phase non-linear regression analysis (NLRA) was used to determine the overall time-to-recurrence for repairs with all three mesh types. Time-to-recurrence was used to validate and predict the year-over-year recurrence data for each specific mesh type.</p><p><strong>Results: </strong>The model found the median overall time-to-recurrence to be longest for long-acting resorbable meshes (166.4 months), followed by synthetic meshes (132.1 months), and shortest for biologic meshes (80 months). At 5 years, about 41% of VHRs with biologic meshes, 27% with synthetic meshes, and 22% with long-acting resorbable meshes are expected to fail due to recurrence; at 10 years, these rates will rise to 65%, 47%, and 39%, respectively. Biologic meshes will have the highest proportion of \\\"at-risk\\\" repairs (42%). At 15-years post-repair 98-99% of the remaining unrecurred VHRs in the biologic and synthetic meshes will remain intact beyond that timepoint. Patients who had VHR with biologic and synthetic mesh should be evaluated for recurrence every 6 months for 2 years, then yearly up to 15 years. Patients repaired with long-acting resorbable meshes should be evaluated for recurrence starting at 12-18 months post-repair, then yearly.</p><p><strong>Conclusions: </strong>We demonstrate the first application of population survival kinetics in the surgery literature. Long-acting resorbable meshes have the longest time-to-recurrence and the lowest recurrence rates over 5 and 10 years, suggesting superior long-term performance compared to synthetic and biologic meshes.</p>\",\"PeriodicalId\":17140,\"journal\":{\"name\":\"Journal of the American College of Surgeons\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-05-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the American College of Surgeons\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/XCS.0000000000001412\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American College of Surgeons","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/XCS.0000000000001412","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

摘要

背景:腹膜疝修补术(vhr)的长期随访结果尚不明确。这些网格在遥远时间点的知识将有助于选择最优的vhr网格。我们的研究旨在建立一个高精度的模型来验证和预测开放vhr的长期复发数据,并进一步确定不同网格的不同vhr的最佳随访时间。研究设计:使用群体生存动力学,一期非线性回归分析(NLRA)来确定所有三种网格类型修复的总复发时间。使用复发时间来验证和预测每种特定网格类型的逐年复发数据。结果:该模型发现长效可吸收补片的中位总复发时间最长(166.4个月),其次是合成补片(132.1个月),最短的是生物补片(80个月)。5年后,约41%使用生物网的vhr、27%使用合成网的vhr和22%使用长效可吸收网的vhr预计会因复发而失效;10年后,这一比例将分别上升至65%、47%和39%。生物网将有最高比例的“风险”修复(42%)。在修复后15年,生物和合成网中98% -99%的未复发vhr将保持完整。使用生物补片和合成补片的VHR患者应每6个月评估一次复发,持续2年,然后每年评估一次,直至15年。使用长效可吸收补片修复的患者应在修复后12-18个月开始评估复发情况,然后每年评估一次。结论:我们展示了种群生存动力学在外科文献中的首次应用。长效可吸收补片的复发时间最长,5年和10年的复发率最低,与合成补片和生物补片相比,具有更好的长期性能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Comparative Long-Term Performance of Biologic, Synthetic, and Long-Acting Resorbable Meshes in Ventral Hernia Repair: Population Survival Kinetics Approach.

Background: Long term follow-up outcomes of ventral hernia repairs (VHRs) with meshes are unavailable. Knowledge of these meshes at distant timepoints will be useful in selecting optimal mesh for VHRs. Our study aims to develop a highly accurate model to validate and predict long-term recurrence data of open VHRs and further determine the optimal timing of follow up for different VHRs with different meshes.

Study design: Using population survival kinetics, one-phase non-linear regression analysis (NLRA) was used to determine the overall time-to-recurrence for repairs with all three mesh types. Time-to-recurrence was used to validate and predict the year-over-year recurrence data for each specific mesh type.

Results: The model found the median overall time-to-recurrence to be longest for long-acting resorbable meshes (166.4 months), followed by synthetic meshes (132.1 months), and shortest for biologic meshes (80 months). At 5 years, about 41% of VHRs with biologic meshes, 27% with synthetic meshes, and 22% with long-acting resorbable meshes are expected to fail due to recurrence; at 10 years, these rates will rise to 65%, 47%, and 39%, respectively. Biologic meshes will have the highest proportion of "at-risk" repairs (42%). At 15-years post-repair 98-99% of the remaining unrecurred VHRs in the biologic and synthetic meshes will remain intact beyond that timepoint. Patients who had VHR with biologic and synthetic mesh should be evaluated for recurrence every 6 months for 2 years, then yearly up to 15 years. Patients repaired with long-acting resorbable meshes should be evaluated for recurrence starting at 12-18 months post-repair, then yearly.

Conclusions: We demonstrate the first application of population survival kinetics in the surgery literature. Long-acting resorbable meshes have the longest time-to-recurrence and the lowest recurrence rates over 5 and 10 years, suggesting superior long-term performance compared to synthetic and biologic meshes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.90
自引率
5.80%
发文量
1515
审稿时长
3-6 weeks
期刊介绍: The Journal of the American College of Surgeons (JACS) is a monthly journal publishing peer-reviewed original contributions on all aspects of surgery. These contributions include, but are not limited to, original clinical studies, review articles, and experimental investigations with clear clinical relevance. In general, case reports are not considered for publication. As the official scientific journal of the American College of Surgeons, JACS has the goal of providing its readership the highest quality rapid retrieval of information relevant to surgeons.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信